NOTICE OF ALLOWANCE - ISSUED
issued
on 11 Jun 2024
Last Applicant/ Owned by
GSK Medicines Research Centre
Stevenage
GB
SG12NY
Serial Number
98010526 filed on 24th May 2023
Registration Number
N/A
Correspondent Address
Elizabeth K. Rucki
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
FILZEPH
Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepat Read More
Classification Information
Class [005]
Pharmaceutical Products
Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98010526
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 84230099
44D Filed
No
44D Current
No
44E filed
Yes
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 07th Nov 2024 | TEAS DELETE 1(B) BASIS RECEIVED |
| 11th Jun 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 16th Apr 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 16th Apr 2024 | PUBLISHED FOR OPPOSITION |
| 27th Mar 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 11th Mar 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 08th Mar 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 08th Mar 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 08th Mar 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 22nd Jan 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |